CARE Ratings (CARERATING) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
18 Nov, 2025Executive summary
Achieved record standalone and consolidated revenues in FY25, driven by strong growth in both domestic and overseas ratings, as well as non-rating verticals.
Board recommended a final dividend of INR 11 per share, totaling INR 18 per share for the year, subject to AGM approval.
Maintained a leading position in the Indian credit ratings market and expanded its global and ESG ratings footprint.
Significant progress in digitization, automation, and AI integration across business processes.
New subsidiary, CareEdge Global IFSC Limited, incorporated in April 2024.
Financial highlights
Consolidated revenue from operations for FY25 was Rs. 40,231.75 lakhs, up 21% year-over-year.
Standalone income from operations reached Rs. 33,668.50 lakhs, up 19% year-over-year.
Consolidated operating profit (EBITDA) was Rs. 15,530 lakhs, up 39% year-over-year, with a 39% margin.
Consolidated PAT increased 37% year-over-year to Rs. 14,000.19 lakhs.
Earnings per share (EPS) for FY25 stood at Rs. 45.89 (consolidated) and Rs. 49.49 (standalone).
Outlook and guidance
GDP growth projected to moderate to 6.2% in FY26, with global uncertainties as key headwinds.
Focus remains on outpacing industry growth, scaling up non-rating businesses, and leveraging technology for efficiency.
Continued investment in people, digital capabilities, and strategic growth drivers.
Board recommended a final dividend of Rs. 11 per share, with total FY25 dividend at Rs. 18 per share, subject to AGM approval.
Latest events from CARE Ratings
- Strong revenue and margin growth, led by ratings, with regulatory and product developments.CARERATING
Q3 25/2611 Feb 2026 - Revenue and PAT rose 19% and 16% year-over-year, led by ratings business; Board reconstituted committees.CARERATING
Q1 24/2518 Nov 2025 - Strong revenue and profit growth, global expansion, and interim dividend declared.CARERATING
Q2 24/2518 Nov 2025 - Strong profit growth, interim dividend, and strategic subsidiary stake sale in Q2 FY26.CARERATING
Q2 25/2614 Nov 2025 - Double-digit growth in income and profits, with stable governance and clean audit review.CARERATING
Q1 25/268 Aug 2025 - Q3FY25 revenue and profit surged YoY, led by ratings and non-ratings growth.CARERATING
Q3 24/255 Jun 2025